Introduction: Coronary artery bypass grafting (CABG), although widely used for a long time in diffuse coronary artery disease (CAD), has serious limitations associated with graft aging and its degeneration.
Introduction
Coronary artery bypass grafting (CABG) is widely applied to treat diffuse coronary artery disease [1] . It offers a significant reduction in mortality at 5-year follow-up compared to medical treatment only (10.2% vs. 15.8%; p = 0.0001) [2] . 88-95% of arterial conduits remain patent at ten or more years after surgery; thus their utilization is a preferred clinical modality. Unfavorably, their use has serious limitations (restrictions in the use of radial artery, mammary artery harvesting may result in sternal dehiscence and/or mediastinitis), particularly in obese and diabetic patients [3] [4] [5] [6] .
In contrast, only 32-71% of saphenous vein grafts (SVG) maintain patency at ten or more years [7] [8] [9] [10] [11] [12] . As the re-do CABG has two-to four-fold increased mortality, percutaneous coronary intervention (PCI) within the SVG and/or native vessel remains the method of choice in the treatment of these cases [13, 14] . Percutaneous coronary intervention for SVG is associated with higher incidence of periprocedural myocardial infarction [15] . There exists a paradigm that atherosclerotic plaque localized in the venous conduits consists of friable tissue being prone to release its debris and cause distal embolization during PCI [16] [17] [18] [19] .
Advances in Interventional Cardiology 2018; 14, 2 (52) There is a paucity of data concerning SVG plaque burden and tissue type. The majority of these observations were made before the introduction of optical coherence tomography (OCT) to the clinical setting. Hence, the question arises whether there is a significant difference between the stenotic and non-stenotic regions of the SVG as assessed by OCT imaging.
Aim
Therefore, the aim of the study was to compare the morphology of SVG in stenotic vs. non-stenotic lesions imaged by OCT, and to present these differences in relation to clinical settings.
Material and methods
Twenty-nine patients hospitalized in the Upper Silesia Medical Center between June 2013 and March 2016 were included in the OCTOPUS registry [20, 21] . Each patient gave informed written content, and the study complied with the Declaration of Helsinki and was accepted by the local ethical committee.
Inclusion criteria were: CABG prior to intervention and coronary artery disease with evidence of active ischemia in non-invasive testing or acute coronary disease. Exclusion criteria were: lack of consent or less than 18 years of age or severe valvular insufficiency or contrast allergy or localization of the lesion preventing safe examination or ST-elevated myocardial infarction.
Optical coherence tomography imaging technique
The lesion was defined as stenotic when it caused 50% stenosis as assessed. Otherwise, it was recognized as non-stenotic. The non-stenotic segments of the vessel were assigned for further analysis. The St Jude Ilumien Optis Medical system was used for OCT Imaging. The OCT Dragonfly catheter was advanced through a guiding catheter over a 0.014' guidewire into the SVG via the 6 Fr left radial or femoral approach. The OCT probe was positioned 5 mm distal to the region submitted to analysis. All OCT images were acquired using automatic pullback triggered by the hand injection of contrast flush. All patients were adequately heparinized with the activated clotting time > 300 s.
Optical coherence tomography image analysis
The OCT image analysis was performed by an independent core laboratory at Krakow Cardiovascular Research Institute (www.KCRI.org). In the case of a conflict of opinions the analyzed frame was excluded from the analysis. The OCT region of interest (ROI) was defined as the lesion length limited by areas without atheroma or neointimal hyperplasia. The OCT analysis scrutinized serial cross-sectional images of the vessel at 1 mm intervals for both stenotic and non-stenotic de novo SVG lesions. Cross-sectional area (CSA), and vessel lumen diameter were measured every 1 mm. The smallest values for both parameters were defined as the minimal lumen diameter (MLD) of the minimal CSA and were assessed for both types of lesions.
The OCT reference lumen area and reference diameter were estimated at the site of the largest CSA within the analyzed SVG for both de novo SVG lesions and non-stenotic lesions. Percentage lumen diameter and area stenosis were defined as the relative decrease in luminal diameter and CSA of the target lesion compared to the reference lumen diameter and CSA.
Tissue was classified as homogeneous for signal-rich regions, lipid for signal-poor regions with diffuse borders and high signal attenuation, calcified for signal-poor regions with sharp edges, and heterogeneous for poor signal regions without signal attenuation. The length of an arc of lipid and calcium that occupied the vessel wall circumference was measured and expressed in degrees [22, 23] . The maximal lipid arc and calcium arc were measured. The thickness of the fibrous cap that covered the lipid core was measured in the thinnest part of a signal-rich zone that separated the lipid content from the vessel lumen (µm). The fibrous cap thickness was the mean value of three measurements. OCT defined thin-cap fibroatheroma (TCFA) as a lipid-rich plaque (LRP) with fibrous cap thickness < 65 µm. Also, the presence of plaque rupture (PRT), luminal thrombus, intimal tear or rupture (ITR), tissue friability (FRB) and venous valves was noted during the OCT analysis. An intimal tear was defined as a micro-cavity between the SVG lumen and its media, intimal rupture as a micro-cavity of the intima connected with the SVG lumen, tissue friability as a signal-free zone overlaid with signal-rich tissue inside the SVG wall [24] . Offline OCT image analysis was performed using CAAS Intravascular 2.0 (Pie Medical Imaging BV), and results of intraobserver variability for standard protocols were presented previously [25] . See Figure 1 for different types of plaque morphologies.
Statistical analysis
Distributions of the examined parameters were analyzed using the Shapiro-Wilk test. Categorical variables were expressed as n and percentage. Continuous variables were expressed as the mean ± standard deviation (SD) or as the median and the 25 th and 75 th percentiles (interquartile range). Linear variables with normal distribution were compared using Student's t-test. Variables with abnormal distribution were compared using the Mann-Whitney U test. Categorical variables of abnormal distribution were compared using the c 2 test with Yates' correction. Differences between the values were considered statistically significant if p < 0.05. Analyses were 
Results

Patients' characteristics
Twenty-nine patients with 32 de novo SVG stenotic and 43 non-stenotic lesions were included in the study. The data for clinical characteristics were depicted on a per patient basis, and the data for plaque morphology were analyzed on a per lesion basis. Percutaneous coronary intervention was performed in 22 of the de novo SVG lesions. The study population consisted of 24 males, mean age 69.07 ±7.56. Mean duration from CABG to the index procedure was 143 (100-212) months. Eighteen (62%) patients presented with stable CAD and 11 (38%) with acute coronary syndrome (ACS). Among ACS patients 10 presented unstable angina symptoms and 1 suffered from non-ST segment elevated myocardial infarction (NSTEMI). For patients' characteristics consisting of clinical data, pharmacological therapy and laboratory findings, see Table I .
Data derived from optical coherence tomography analysis of saphenous vein grafts
As shown in Table II , stenotic vs. non-stenotic lesions were characterized by a raised plaque burden expressed by lowered MLD (1.88 vs. 2.83 mm), increased area stenosis (61.00% vs. 15.05%), diameter stenosis (37.33% vs. 3.0%) and maximal lipid arc (269° vs. 97°); p < 0.001 for all. Furthermore, stenotic lesions had a higher incidence of TCFA (33% vs. 0%, p = 0.0048), thrombus (28% vs. 0%, p = 0. /µl, p = 0.008) and were smokers (27% vs. 0%, p = 0.020). Data are presented in Table III .
As presented in Table IV , patients with calcified lesions (CAL) had decreased HDL cholesterol (33.2 vs. 44.1 mg/dl, p = 0.018), similarly to those with ruptured plaque (PRT) (28.3 vs. 41.7 mg/dl, p = 0.047). 
Discussion
According to our best knowledge, there is a lack of systematic comparison between stenotic vs. non-stenotic lesions assessed by OCT; thus, we encountered serious difficulties in addressing the issue in the previously published papers. Our observations concerning stenotic lesions are in line with the work of Davlouros et al. [24] with the exception that the ACS in our group of patients occurred in the minority of cases (11 ACS vs. 18 patients with stable angina), hence TCFA, PRT and ITR were considerably less frequent. What might be a novelty in the current research is that only TCFA, LRP, thrombus and plaque within the valve had a higher incidence rate in stenotic lesions compared to non-stenotic ones. In contrast, presence of PRT, ITR and FRB did not differ significantly. Adlam et al. [26] evaluated sixteen SVGs in asymptomatic patients 3 years after cardiac surgery and reported that the rates of TCFA and thrombus were 37.5% and 25% respectively. These data are consistent with our results -incidence of TCFA and thrombus were 33% and 28% respectively. Considering the significant imbalance between the time from CABG in Adlam's (3 years) and our (12 years) group of patients, it is tempting to speculate that the thrombus and TCFA formation accelerates in a non-linear way and a major impact on its occurrence is exerted by the quality of conduit tissue and periprocedural surgical conditions. Burgmaier et al. reported the relationship between plaque vulnerability and the left ventricle dilatation assessed by cardiac magnetic resonance , p = 0.010). These data are in line with the previous results of Burgmaier et al., although some important differences should be addressed. First of all, we assessed the patients in a real-world setting; hence LVEF evaluation was performed by the use of ultrasound imaging and the penetration of HF is considerable (21% of patients with LVEF ≤ 35%). Secondly, despite Table IV . Clinical and imaging findings depending on tissue type according to OCT imaging Parameter CAL-0 (n = 27) Mean ± SD CAL-1 (n = 16) Mean ± SD
P-value
PRT-0 (n = 39) Mean ± SD PRT-1 (n = 4) Mean ± SD we suggest initiating a randomized control trial of SVGs after cardiac surgery to address the issue of OCT-derived plaque morphology with respect to hypothetical clinical benefit in this therapeutically demanding group of patients. This is a preliminary study that enrolled a relatively small number of patients. As it was performed in one center, although the researchers did not interfere with the management process, there exists a possibility of selection bias. Despite the fact that it was recently widely discussed and considered insignificant, since OCT is an invasive procedure there exists a theoretical possibility of iatrogenic damage of the vessel wall which might have influenced the results.
